2seventy bio Overview
Get informed when a big investor buys or sells
+ Follow-1.91%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for TSVT is -1.91%. That is below the sector sector average of 11.85%. Investors often review this figure alongside 2seventy bio's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, TSVT currently prints -1.91% for ROE, while the sector average sits near 11.85%. That is roughly 116.1% below the sector mean. Large gaps often invite a closer look at 2seventy bio's growth, margins, and balance sheet.
Return on Equity shows how effectively 2seventy bio converts resources into returns. At -1.91%, TSVT may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting TSVT's ROE (-1.91%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
